Description
Yeztugo® (Lenacapavir Injection)
Yeztugo® (lenacapavir injection) is a long-acting prescription medication developed for HIV prevention in eligible adults and adolescents. Administered as a subcutaneous injection every six months after the recommended initiation regimen, Yeztugo offers a convenient, long-duration dosing schedule that may improve treatment adherence for individuals seeking an alternative to daily oral medication.
Lenacapavir belongs to a novel class of antiviral medications known as HIV-1 capsid inhibitors. It works by interfering with multiple stages of the HIV life cycle, helping reduce the risk of HIV acquisition when used as prescribed.
Key Features
- Long-acting injectable formulation
- Administered once every six months after initiation
- Innovative HIV-1 capsid inhibitor
- Prescription medication for eligible patients
- May improve adherence by reducing dosing frequency
- Intended for use under the supervision of a qualified healthcare provider
Product Information
- Generic Name: Lenacapavir Injection
- Brand Name: Yeztugo®
- Dosage Form: Subcutaneous Injection
- Therapeutic Class: HIV-1 Capsid Inhibitor
- Administration: Healthcare professional administration as prescribed
At Pure Axis Distribution, we are committed to supplying authentic pharmaceutical products sourced from trusted manufacturers. We provide reliable distribution services, competitive pricing, and responsive customer support to healthcare providers, clinics, pharmacies, and authorized purchasers.
Reviews
There are no reviews yet.